These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 15701783

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quality of anticoagulation monitoring in nonvalvular atrial fibrillation patients: comparison of anticoagulation clinic versus usual care.
    Nichol MB, Knight TK, Dow T, Wygant G, Borok G, Hauch O, O'Connor R.
    Ann Pharmacother; 2008 Jan; 42(1):62-70. PubMed ID: 18094348
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Results of an open-label, prospective study of anticoagulant therapy for atrial fibrillation in an outpatient anticoagulation clinic.
    Abdelhafiz AH, Wheeldon NM.
    Clin Ther; 2004 Sep; 26(9):1470-8. PubMed ID: 15531009
    [Abstract] [Full Text] [Related]

  • 5. Direct costs of warfarin treatment among patients with atrial fibrillation in a Finnish health care setting.
    Hallinen T, Martikainen JA, Soini EJ, Suominen L, Aronkytö T.
    Curr Med Res Opin; 2006 Apr; 22(4):683-92. PubMed ID: 16684429
    [Abstract] [Full Text] [Related]

  • 6. Occurrence and quality of anticoagulant treatment of chronic atrial fibrillation in primary health care in Sweden: a retrospective study on electronic patient records.
    Nilsson GH, Björholt I.
    BMC Clin Pharmacol; 2004 Feb 09; 4():1. PubMed ID: 15028124
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
    Jacobs LG, Billett HH, Freeman K, Dinglas C, Jumaquio L.
    Am J Geriatr Pharmacother; 2009 Jun 09; 7(3):159-66. PubMed ID: 19616184
    [Abstract] [Full Text] [Related]

  • 9. Health care expenditures and therapeutic outcomes of a pharmacist-managed anticoagulation service versus usual medical care.
    Hall D, Buchanan J, Helms B, Eberts M, Mark S, Manolis C, Peele P, Docimo A.
    Pharmacotherapy; 2011 Jul 09; 31(7):686-94. PubMed ID: 21923456
    [Abstract] [Full Text] [Related]

  • 10. Should hemodialysis patients with atrial fibrillation undergo systemic anticoagulation? A cost-utility analysis.
    Quinn RR, Naimark DM, Oliver MJ, Bayoumi AM.
    Am J Kidney Dis; 2007 Sep 09; 50(3):421-32. PubMed ID: 17720521
    [Abstract] [Full Text] [Related]

  • 11. Effect of heart failure exacerbations on anticoagulation: a prospective, observational, pilot cohort study.
    Ripley TL, Harrison D, Germany RE, Adamson PB.
    Clin Ther; 2010 Mar 09; 32(3):506-14. PubMed ID: 20399987
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Effect of a warfarin adherence aid on anticoagulation control in an inner-city anticoagulation clinic population.
    Nochowitz B, Shapiro NL, Nutescu EA, Cavallari LH.
    Ann Pharmacother; 2009 Jul 09; 43(7):1165-72. PubMed ID: 19549747
    [Abstract] [Full Text] [Related]

  • 14. Retrospective study of total healthcare costs associated with chronic nonvalvular atrial fibrillation and the occurrence of a first transient ischemic attack, stroke or major bleed.
    Boccuzzi SJ, Martin J, Stephenson J, Kreilick C, Fernandes J, Beaulieu J, Hauch O, Kim J.
    Curr Med Res Opin; 2009 Dec 09; 25(12):2853-64. PubMed ID: 19916729
    [Abstract] [Full Text] [Related]

  • 15. Cost-effectiveness of warfarin: trial versus "real-world" stroke prevention in atrial fibrillation.
    Sorensen SV, Dewilde S, Singer DE, Goldhaber SZ, Monz BU, Plumb JM.
    Am Heart J; 2009 Jun 09; 157(6):1064-73. PubMed ID: 19464418
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of two different models of anticoagulation management services with usual medical care.
    Rudd KM, Dier JG.
    Pharmacotherapy; 2010 Apr 09; 30(4):330-8. PubMed ID: 20334453
    [Abstract] [Full Text] [Related]

  • 18. Atrial fibrillation and stroke prevention with warfarin in the long-term care setting.
    Gurwitz JH, Monette J, Rochon PA, Eckler MA, Avorn J.
    Arch Intern Med; 1997 May 12; 157(9):978-84. PubMed ID: 9140268
    [Abstract] [Full Text] [Related]

  • 19. Effect of access to anticoagulation management services on warfarin use in patients with atrial fibrillation.
    Burkiewicz JS.
    Pharmacotherapy; 2005 Aug 12; 25(8):1062-7. PubMed ID: 16207096
    [Abstract] [Full Text] [Related]

  • 20. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis.
    Ali A, Bailey C, Abdelhafiz AH.
    Age Ageing; 2012 Sep 12; 41(5):681-4. PubMed ID: 22378612
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.